This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Preventing infection in patients with malignant melanoma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Preventing infection

  • offer people with myeloma the seasonal influenza vaccination

  • consider extending the pneumococcal vaccination to people with myeloma who are under 65

  • consider intravenous immunoglobulin replacement therapy for people who have hypogammaglobulinaemia and recurrent infections

  • consider continuing aciclovir or equivalent antiviral prophylaxis after treatment with bortezomib or other proteasome inhibitors ends

  • consider aciclovir or equivalent antiviral prophylaxis for people who are taking both immunomodulatory drugs and high-dose steroids

  • consider testing for hepatitis B, hepatitis C and HIV before starting myeloma treatment.

Reference:

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.